Literature DB >> 11834665

Left ventricular remodeling, systolic function, and diastolic function in young adults with beta-thalassemia intermedia: a Doppler echocardiography study.

Marco Vaccari1, Roberto Crepaz, Monica Fortini, Maria R Gamberini, Sabrina Scarcia, Walter Pitscheider, Giuliano Bosi.   

Abstract

BACKGROUND: The aim of this study was to investigate the left ventricular (LV) remodeling and function in 24 asymptomatic young adults affected by beta-thalassemia intermedia (TI), in order to compare the obtained data with that of 80 patients affected by beta-thalassemia major (TM) and 65 healthy subjects.
METHODS: LV volumes and shapes, mass index, mass/volume ratio, systolic and diastolic function, stroke volume, and cardiac index were determined by two-dimensional and M-mode echocardiography.
RESULTS: In the TM and TI groups, LV volumes, diastolic and systolic shapes were significantly different from the control subjects, but the ejection fraction was slightly reduced only in the TM group. The TI group had larger LV volumes than did the TM group (mean [+/- SD] end-diastolic volume index, 99.4 +/- 21.9 vs 82.7 +/- 21.5 mL/m(2), respectively [p < 0.005]; mean end-systolic volume index, 42.8 +/- 12.2 vs 36.1 +/- 12.9 mL/m(2), respectively [p < 0.05]). Both groups showed an increase of the LV mass index, but the mass/volume ratio did not differ from the control subjects. The systolic volume index and the cardiac index were increased in both groups, but the increase was more pronounced in the TI group. Fractional shortening (FS) and the mean velocity of circumferential shortening (mVCFc) were decreased in the TM group (FS, 33.6 +/- 5.5% vs 36.9 +/- 4.1, respectively [p < 0.001]; mVCFc, 1.06 +/- 0.18 vs 1.17 +/- 0.12 circumference per second, respectively [p < 0.0001]). The LV contractile state was depressed only in the TM group, and the preload index was normal in both. LV filling showed an increase in the total flow velocity integral due to increases in the peak E wave (E) and peak A wave (A) velocities and integrals, with an increase of the E/A ratio in the TM group and a slight decrease in the TI group. The isovolumic relaxation time was prolonged in both groups. There was no major derangement in the pulmonary venous flow.
CONCLUSIONS: Asymptomatic young adults with TI show significant increases in LV volumes, LV mass, and cardiac index that are more pronounced than those in TM patients. LV systolic function is preserved in the TI group but is slightly depressed in the TM group due to the increase of afterload and to reduced contractility. The hemodynamic and hematologic factors involved in the etiopathogenesis of these findings are discussed, such as the treatment strategy.

Entities:  

Mesh:

Year:  2002        PMID: 11834665     DOI: 10.1378/chest.121.2.506

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with beta-thalassemia major: a 10-year (1995--2004) follow-up.

Authors:  Christina Chrysohoou; Demosthenes B Panagiotakos; Yannis Barbetseas; Stella Brilli; Spyros Lambrou; Markissia Karagiorga; Vassilis A Ladis; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

2.  Early echocardiographic findings in β-thalassemia intermedia patients using standard and tissue Doppler methods.

Authors:  Hamid Amoozgar; Nahal Farhani; Mehran Karimi
Journal:  Pediatr Cardiol       Date:  2010-11-17       Impact factor: 1.655

3.  Ventriculo-vascular interactions in patients with beta thalassaemia major.

Authors:  Y F Cheung; S Y Ha; G C F Chan
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

4.  Anesthetic management of a patient with beta-thalassemia intermedia undergoing splenectomy: a case report.

Authors:  Takeshi Kitoh; Satoshi Tanaka; Koichi Ono; Joe Hasegawa; Tetsutaro Otagiri
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

5.  Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia.

Authors:  Roya Isa Tafreshi; Mohammad Radgoodarzi; Kadijeh Arjmandi Rafsanjani; Fahimeh Soheilipour
Journal:  Front Pediatr       Date:  2022-06-17       Impact factor: 3.569

6.  Left ventricular remodelling, and systolic and diastolic function in young adults with beta thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data.

Authors:  G Bosi; R Crepaz; M R Gamberini; M Fortini; S Scarcia; E Bonsante; W Pitscheider; M Vaccari
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

7.  Early detection of right ventricular diastolic dysfunction by pulsed tissue Doppler echocardiography in iron loaded beta thalassemia patients.

Authors:  Hala Mounir Agha; Amal Beshlawy; Mona Hamdy; Alae Sobeih; Fatma El Zahrae; Inas Abd Abd El Satar; Antoine AbdelMassih; Fadwa Said; Ossama Abd El Aziz; Mona El Tagui; Dudley J Pennell
Journal:  Pediatr Cardiol       Date:  2014-10-08       Impact factor: 1.655

8.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

9.  Comparison of right and left side heart functions in patients with thalassemia major, patients with thalassemia intermedia, and control group.

Authors:  Noormohammad Noori; Mehdi Mohamadi; Kambiz Keshavarz; Seyed Mostafa Alavi; Maziar Mahjoubifard; Yalda Mirmesdagh
Journal:  J Tehran Heart Cent       Date:  2013-01-08

10.  The Diagnostic Value of Pulsed Wave Tissue Doppler Imaging in Asymptomatic Beta- Thalassemia Major Children and Young Adults; Relation to Chemical Biomarkers of Left Ventricular Function and Iron Overload.

Authors:  Seham M Ragab; Waleed M Fathy; Walaa FAbd El-Aziz; Rasha T Helal
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-08-24       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.